HOME >> MEDICINE >> NEWS
New awards, expanded focus for Pediatric AIDS Clinical Trials Group

The National Institute of Allergy and Infectious Diseases (NIAID) today announced $36 million in renewed funding for the Pediatric AIDS Clinical Trials Group (PACTG), and a greater focus on both adolescent research and international pediatric research. The new five-year awards will support 18 university-based clinical trials sites, a statistical and data management center, and a coordinating and operations center.

The PACTG has pioneered key trials evaluating treatments for children with HIV and has made great advances in reducing the rate of mother-to-infant HIV transmission in the developed world. The epidemic among adolescents in the United States, however, has become an increasing concern. The Centers for Disease Control and Prevention reports that 4,219 cumulative cases of AIDS among adolescents, or children ages 13 through 19, were reported through June 2001,(1) and the number of adolescents living with HIV is estimated to be much higher.

Because the average length of time between HIV infection and the development of AIDS is 10 years, it is believed that many adults became infected as adolescents. Most adolescents infected with HIV are at an early stage of disease and are ideal candidates for early intervention and treatment strategies.

HIV and AIDS also continue to take a devastating toll on women and children in developing countries, where more than 90 percent of all HIV/AIDS cases occur. In 2001, approximately 2.7 million children younger than age 15 were living with HIV/AIDS worldwide, and 580,000 children in this age group died from HIV-associated illnesses or AIDS, according to a UNAIDS report.(2) In addition to the suffering of children, 48 percent of adults living with HIV/AIDS in the world are women, many of whom are of childbearing age.(2) To this end, the PACTG will also directly support clinical research at four international sites, two in South Africa and two in Thailand.

"The Pediatric AIDS Clinical Trials
'"/>

Contact: Diana K. Carroll
dcarroll@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases
7-Mar-2002


Page: 1 2 3 4 5

Related medicine news :

1. Routine HIV screening should be expanded, study finds
2. Partnership for Prevention and ACPM commend expanded coverage of preventive services under Medicare
3. Study of energy and health in Africa focuses spotlight on charcoal and forest management
4. Protecting human subjects focus of national FDA conference at UH
5. Non-lethal weapons focus of research study
6. Insulin resistance intervention after stroke focus of $33 million grant
7. Ethics of neuroimaging research to be focus of NIH/Stanford meeting
8. TIGER Workshop puts focus on space for African water management
9. UCI launches nations first medical education program focused on Latino culture
10. New initiative to focus on growing problem of cardiovascular disease in diabetics
11. Apraxia of speech in children is focus of new OHSU grant

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/25/2016)... California (PRWEB) , ... June 25, 2016 , ... "With ... fit their specific project," said Christina Austin - CEO of Pixel Film Studios. ... customizable and all within Final Cut Pro X . Simply select a ProHand ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, ... the latter, setting the bar too high can result in disappointment, perhaps even self-loathing. ... toward their goal. , Research from PsychTests.com reveals that behind the ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Scientific Sessions in Dallas that it will receive two significant new grants to ... came as PHA marked its 25th anniversary by recognizing patients, medical professionals and ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. ... magazine’s Code Talker Award, an essay contest in which patients and their families pay ... be presented at the 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference ...
(Date:6/24/2016)... ... ... National recruitment firm Slone Partners is pleased to announce the placement of ... President of North American Capital Sales at HTG Molecular . , ... the commercialization of the HTG EdgeSeq system and associated reagents in North America. , ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 2016 Research and Markets has ... by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), ... Parenteral) - Global Forecast to 2021" report to ... The global pharmaceutical excipients market is projected to reach ... 6.1% in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... June 23, 2016 Roche (SIX: RO, ROG; ... for its Elecsys BRAHMS PCT (procalcitonin) assay as a ... septic shock. With this clearance, Roche is the first ... integrated solution for sepsis risk assessment and management. ... infection and PCT levels in blood can aid clinicians ...
(Date:6/23/2016)... , June 23, 2016 ... CAPR ), a biotechnology company focused on the ... announced that patient enrollment in its ongoing randomized ... has exceeded 50% of its 24-patient target. Capricor ... the third quarter of 2016, and to report ...
Breaking Medicine Technology:
Cached News: